Cerebral perfusion after a 2-year remission in major depression

International Journal of Neuropsychopharmacology

Volumn 11, Issue 6, 2008, Pages 837-843

  Kohn, Yoav ^a   Freedman, Nanette ^a   Lester, Hava ^a   Krausz, Yodphat ^a   Chisin, Roland ^a   Lerer, Bernard ^a   Bonne, Omer ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

HMPAO SPECT; Major depression; rCBF; Remission

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BRAIN MAPPING; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; MAJOR DEPRESSION; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; REMISSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 50849135599     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708008936     Document Type: Article

References (25)

1. Bonne O, Krausz Y, Aharon Y, Gelfin Y, Chisin R, Lerer B (1999). Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers. Psychopharmacology (Berlin) 143, 24-28.
2. Bonne O, Krausz Y, Shapira B, Bocher M, Karger H, Gorfine M, Chisin R, Lerer B (1996). Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. Journal of Nuclear Medicine 37, 1075-1080.
3. Brown DR, Hunter R, Wyper DJ, Patterson J, Kelly RC, Montaldi D, McCullouch J (1996). Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study. Journal of Psychiatric Research 30, 109-126.
4. Drevets WC, Bogers W, Raichle ME (2002). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology 12, 527-544.
5. Ecdeu GW (1976). Assessment Manual for Psychopharmacology (pp. 217-222). Rockville, MD: National Institute of Mental Health.
6. Geday J, Hermansen F, Rosenberg R, Smith DF (2005). Serotonin modulation of cerebral blood flow measured with positron emission tomography (PET) in humans. Synapse 55, 224-229.
7. Goodwin GM, Austin MP, Dougall N, Ross M, Murray C, O'Carroll RE, Moffoot A, Prentice N, Ebmeier KP (1993). State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. Journal of Affective Disorders 29, 243-253.
8. Holthoff VA, Beuthien-Baumann B, Zundorf G, Triemer A, Ludecke S, Winiecki P, Koch R, Fuchtner F, Herholz K (2004). Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatrica Scandinavica 110, 184-194.
9. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Mueller TI, Rice JP, Keller MB (2000). Psychosocial disability during the long-term course of unipolar major depressive disorder. Archives of General Psychiatry 57, 375-380.
10. Kohn Y, Freedman N, Lester H, Krausz Y, Chisin R, Lerer B, Bonne O (2007). Tc-99m HMPAO SPECT study of cerebral perfusion after treatment with medication and electroconvulsive therapy in major depression. Journal of Nuclear Medicine 48, 1273-1278.
11. Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P (2002). Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. American Journal of Psychiatry 159, 1830-1840.
12. Mayberg HS (2003). Modulating dysfunctional limbiccortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 65, 193-207.
13. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 48, 830-843.
14. Navarro V, Gasto C, Lomena F, Mateos JJ, Marcos T, Portella MJ (2002). Normalization of frontal cerebral perfusion in remitted elderly major depression: a 12-month follow-up SPECT study. Neuroimage 16, 781-787.
15. Navarro V, Gasto C, Lomena F, Mateos JJ, Portella MJ, Massana G, Bernardo M, Marcos T (2004a). Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression: a 12-month follow-up control study. Journal of Clinical Psychiatry 65, 656-661.
16. Navarro V, Gastó C, Lomeña F, Torres X, Mateos JJ, Portella MJ, Masana G, Marcos T (2004b). Prognostic value of frontal functional neuroimaging in late-onset severe major depression. British Journal of Psychiatry 184, 306-311.
17. Passero S, Nardini M, Battistini N (1995). Regional cerebral blood flow changes following chronic administration of antidepressant drugs. Progress in Neuropsychopharmacology and Biological Psychiatry 19, 627-636.
18. Rapoport M, van Reekum R, Mayberg H (2000). The role of the cerebellum in cognition and behavior: a selective review. Journal of Neuropsychiatry and Clinical Neuroscience 12, 193-198.
19. Schmahmann J (2000). The role of the cerebellum in affect and psychosis. Journal of Neurolinguistics 13, 189-214.
20. Schmahmann JD (2004). Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. Journal of Neuropsychiatry and Clinical Neuroscience 16, 367-378.
21. Sheline YI (2003). Neuroimaging studies of mood disorder effects on the brain. Biological Psychiatry 54, 338-352.
22. Silfverskiold P, Gustafson L, Risberg J, Rosen I (1986). Acute and late effects of electroconvulsive therapy. Clinical outcome, regional cerebral blood flow, and electroencephalogram. Annals of the New York Academy of Science 462, 236-248.
23. Silfverskiold P, Risberg J (1989). Regional cerebral blood flow in depression and mania. Archives of General Psychiatry 46, 253-259.
24. Smith DJ, Cavanagh JT (2005). The use of single photon emission computed tomography in depressive disorders. Nuclear Medicine Communications 26, 197-203.
25. Videbech P, Ravnkilde B (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 161, 1957-1966.